Waking Up to REMS (Part 1): Don't Believe the Lack of Hype

FDA's top management can't be accused of overstating the importance of the agency's new drug safety tools. But sponsors need to wake up to the reality: the REMS are a critical fact of drug development and marketing.

More from Agency Leadership

More from Pink Sheet